Research Regulatory Compliance (eBook)

Mark A. Suckow, Bill Yates (Herausgeber)

eBook Download: PDF | EPUB

2015 | 1. Auflage
344 Seiten
Elsevier Science (Verlag)
978-0-12-420065-4 (ISBN)

Research Regulatory Compliance offers the latest information on regulations and compliance in the laboratory. With the increasing complexity of regulations and need for institutional infrastructure to deal with compliance of animal use issues, as well as a requirement surrounding human subjects, this publication provides reputable guidance and information. The book is extremely helpful as a resource for researchers, administrators, and technicians in the laboratory, and is also a great asset for faculty or new researchers coming in to the laboratory environment. It will help prepare users for the deluge of regulatory and compliance issues they will face while conducting their scientific programs. The book is edited and authored by known leaders in the field of compliance and regulations, and contains extensive research on the topics. It represents the new standard for information in every laboratory. - Provides a 'one-stop' , go-to resource for the many regulatory and compliance issues that affect laboratory study and research models - Extremely helpful as a resource for researchers, administrators, and technicians in the laboratory, and also a great asset for faculty or new researchers coming in to the laboratory environment - Focuses on United States regulations, covering both animal models and human subjects - Written and edited by known leaders in the field of regulatory compliance who bring many years of collective experience to the book

Research Regulatory Compliance offers the latest information on regulations and compliance in the laboratory. With the increasing complexity of regulations and need for institutional infrastructure to deal with compliance of animal use issues, as well as a requirement surrounding human subjects, this publication provides reputable guidance and information. The book is extremely helpful as a resource for researchers, administrators, and technicians in the laboratory, and is also a great asset for faculty or new researchers coming in to the laboratory environment. It will help prepare users for the deluge of regulatory and compliance issues they will face while conducting their scientific programs. The book is edited and authored by known leaders in the field of compliance and regulations, and contains extensive research on the topics. It represents the new standard for information in every laboratory. - Provides a "e;one-stop"e; , go-to resource for the many regulatory and compliance issues that affect laboratory study and research models- Extremely helpful as a resource for researchers, administrators, and technicians in the laboratory, and also a great asset for faculty or new researchers coming in to the laboratory environment- Focuses on United States regulations, covering both animal models and human subjects- Written and edited by known leaders in the field of regulatory compliance who bring many years of collective experience to the book

Chapter 1

Human Subjects Research Protections

John R. Baumann, Heather Mullins-Owens, David Russell, and Amy Waltz Indiana University, Indianapolis and Bloomington, IN, USA

Abstract

The aim of this chapter is to present an overview of the history, processes, and selected issues related to the institutional oversight of human subjects research. Our beginning point is the human research protection program (HRPP). An HRPP encompasses all aspects and components of an institution involved in conduct and oversight of human subjects research—in other words, more than just the Institutional Review Board (IRB) or Research Ethics Committee (REC) itself. This chapter begins with a historical perspective—a discussion of some of the practices and processes that gave rise to our contemporary principles of, and processes for, human subject research protections. An overview of the regulatory context follows: review of the major regulatory mandates and the regulatory agencies as well as committees empowered to oversee and implement those mandates. The chapter concludes with a discussion of common challenges, mechanisms for addressing or preventing noncompliance issues, and, finally, a discussion of some of the issues that may shape the future directions of human subjects protection.

Keywords

Belmont Report; HRPP; Human subjects research; Noncompliance; Nuremberg code; Syphilis study

1. Introduction

A researcher from the school of business seeks to enroll students in a study to assess variables that might influence levels of risk tolerance and aversion.

An anthropologist proposes an ethnographic study of disruptions in a local market in a Mexican community on the opening of a “big box” store in the near vicinity.

An oncologist proposes a study to test the safety of an investigational new drug (drug C) in patients with multiple myeloma. Patients participating in the study will receive either Treatment Arm 1 (drugs O, L, and D) or Treatment Arm 2 (drugs O, C, and D). The chances of being assigned to either treatment are approximately 50/50.

A sociologist proposes a mixed methods study to assess the impact of a recent hurricane on the city’s pattern of illegal drug use and illegal drug markets. Similar research will take place in two surrounding communities to which residents were re-located.

A physician-researcher proposes to access the electronic medical records of all patients undergoing a new presurgical preparation procedure to determine whether they have better outcomes than patients who do not undergo the procedure.

A school of education professor seeks to explore the relative effectiveness of three pedagogical approaches for teaching language arts to elementary school students.

A psychologist is funded to investigate and further develop a new approach for reducing “burn out” among the professional and paraprofessional staff of substance abuse and mental health service agencies.

The research studies summarized above are all very different from one another: different subject populations, different academic disciplines, different procedures, different methodologies, operating from different paradigms, and so on. However, they share one crucial factor: They are each an example of human subject research that requires the research team to submit their project to their institution’s human research protection program (HRPP) for review and approval in advance of initiation.

• The organization. By organization, AAHRPP is referring to more than the office that receives studies for IRB review, sometimes named the IRB office, human subjects office, or compliance office. It refers, rather to a host of administrative components and features of organizational culture and practice in addition to that office. This may include, but is not limited to: the institutional official, other compliance committees (such as conflict of interest and radiation safety), grant/contracts office, pharmacy, and a host of activities beyond the review of individual studies.

• The IRB or REC itself. This is the specific group of individuals that has the responsibility and authority to review and approve, disapprove, or table human subject research studies.

• The researchers. These are researchers and research staff who are responsible for, and involved, in the design, conduct, and reporting of human subject research.

This chapter begins with a historical perspective—a discussion of some of the practices and processes that gave rise to our contemporary principles of, and processes for, human subject research protections. An overview of the regulatory context follows: review of the major regulatory mandates, the regulatory agencies, and committees empowered to oversee and implement those mandates. The chapter concludes with a discussion of common challenges, mechanisms for addressing or preventing noncompliance issues, and, finally, a discussion of some of the issues that may shape the future directions of human subject protection.

2. Historical Perspectives

2.1. Recognition of Need

The practice of research on humans is, of course, long standing. Even a quick review of medical history reveals countless examples of this. However, the formal idea and regulation of “human subjects research” is recent and was, like many such reforms, generated by a controversy. Serious ethical issues arising from the Tuskegee syphilis experiments in 1972 caused a moral outrage [1–3]. Congress was moved to act and in 1974 passed the National Research Act, which established the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. From 1974 to 1978, the commission issued several reports related to biomedical and behavioral research with human subjects, culminating in 1979 with their final, formal report known as the Belmont Report, named after the conference room in which they met [4]. The Belmont Report summarized the basic ethical principles and corresponding guidelines that the commission recognized for the conduct of human experimentation. Principles and codes addressing the conduct of human subject research have existed in various forms and have been followed by a variety of organizations since the mid 1940s, but the Belmont Report has arguably had the greatest effect on human subject research protections in the United States.

The Belmont Report’s ethical principles and guidelines address key areas of concern following the aforementioned Tuskegee syphilis study. Officially known as the Tuskegee Study of Untreated Syphilis in the Negro Male, the study was sponsored by the United States Public Health Service and was conducted between 1932 and 1972. As the title suggests, the study aimed to follow the progression of untreated syphilis in the human body with a target study population of black males. Subjects infected with syphilis, and some who were not infected, were recruited into the study with the promise of medical care, free food, and burial insurance. The subjects were not informed of the true nature of the procedures to which they agreed and were told only that they were being treated for “bad blood” [1–3]. The researchers deliberately withheld penicillin and other treatments that were developed during the course of the study from the subjects so they could monitor and document the progression of the disease. As both a direct and indirect consequence, subjects experienced psychological/cognitive distress, physical deficiencies, and even death. Further, the disease may well have been transmitted to sexual partners and children born to research participants.

The core principles and practices identified in the Belmont Report were central to the public outcry regarding the overall conduct of this research and the treatment of the research subjects: patient autonomy, lack of informed consent, the direct harm done to subjects due to withholding medical care, and the unequal/inequitable distribution of research risks on one segment of the population. The Belmont Report identified three key ethical principles for the practice of human subject research: respect for persons, beneficence, and justice. Emerging from these three principles were three guidelines for their implementation or actualization: informed consent, assessment of risk and benefit, and equitable sharing of the burdens and benefits of research [4,5].

Respect for persons specifically addresses patient autonomy and requires that, as autonomous beings, subjects should be afforded the right to be informed of the procedures being performed in the research in which they are asked to participate and that their participation be voluntary. The Belmont Report describes an autonomous human being as one capable of self-determination and consideration of a variety of choices based on...

Erscheint lt. Verlag	14.6.2015
Sprache	englisch
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Diabetologie
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
ISBN-10	0-12-420065-6 / 0124200656
ISBN-13	978-0-12-420065-4 / 9780124200654

Haben Sie eine Frage zum Produkt?

PDF (Adobe DRM)
Größe: 2,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUB (Adobe DRM)
Größe: 2,9 MB

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Print-Ausgabe

Buch | Hardcover

92,25 €